117 research outputs found
Molecular Gas in the Host Galaxy of a Quasar at Redshift z=6.42
Observations of the molecular gas phase in quasar host galaxies provide
fundamental constraints on galaxy evolution at the highest redshifts. Molecular
gas is the material out of which stars form; it can be traced by spectral line
emission of carbon--monoxide (CO). To date, CO emission has been detected in
more than a dozen quasar host galaxies with redshifts (z) larger 2, the record
holder being at z=4.69. At these distances the CO lines are shifted to longer
wavelengths, enabling their observation with sensitive radio and millimetre
interferometers. Here we present the discovery of CO emission toward the quasar
SDSS J114816.64+525150.3 (hereafter J1148+5251) at a redshift of z=6.42, when
the universe was only 1/16 of its present age. This is the first detection of
molecular gas at the end of cosmic reionization. The presence of large amounts
of molecular gas (M(H_2)=2.2e10 M_sun) in an object at this time demonstrates
that heavy element enriched molecular gas can be generated rapidly in the
earliest galaxies.Comment: 12 pages, 2 figures. To appear in Nature, July, 200
Statistics of 207 Lya Emitters at a Redshift Near 7: Constraints on Reionization and Galaxy Formation Models
We present Lya luminosity function (LF), clustering measurements, and Lya
line profiles based on the largest sample, to date, of 207 Lya emitters (LAEs)
at z=6.6 on the 1-deg^2 sky of Subaru/XMM-Newton Deep Survey (SXDS) field. Our
z=6.6 Lya LF including cosmic variance estimates yields the best-fit Schechter
parameters of phi*=8.5 +3.0/-2.2 x10^(-4) Mpc^(-3) and L*(Lya)=4.4 +/-0.6
x10^42 erg s^(-1) with a fixed alpha=-1.5, and indicates a decrease from z=5.7
at the >~90% confidence level. However, this decrease is not large, only =~30%
in Lya luminosity, which is too small to be identified in the previous studies.
A clustering signal of z=6.6 LAEs is detected for the first time. We obtain the
correlation length of r_0=2-5 h^(-1) Mpc and bias of b=3-6, and find no
significant boost of clustering amplitude by reionization at z=6.6. The average
hosting dark halo mass inferred from clustering is 10^10-10^11 Mo, and duty
cycle of LAE population is roughly ~1% albeit with large uncertainties. The
average of our high-quality Keck/DEIMOS spectra shows an FWHM velocity width of
251 +/-16 km s^(-1). We find no large evolution of Lya line profile from z=5.7
to 6.6, and no anti-correlation between Lya luminosity and line width at z=6.6.
The combination of various reionization models and our observational results
about the LF, clustering, and line profile indicates that there would exist a
small decrease of IGM's Lya transmission owing to reionization, but that the
hydrogen IGM is not highly neutral at z=6.6. Our neutral-hydrogen fraction
constraint implies that the major reionization process took place at z>~7.Comment: 28 pages, 23 figures. Accepted for publication in Ap
Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort
<p>Abstract</p> <p>Background</p> <p>Only a limited number of studies have performed comprehensive investigations of coding variation in relation to breast cancer risk. Given the established role of estrogens in breast cancer, we hypothesized that coding variation in steroid receptor coactivator and corepressor genes may alter inter-individual response to estrogen and serve as markers of breast cancer risk.</p> <p>Methods</p> <p>We sequenced the coding exons of 17 genes (<it>EP300, CCND1, NME1, NCOA1, NCOA2, NCOA3, SMARCA4, SMARCA2, CARM1, FOXA1, MPG, NCOR1, NCOR2, CALCOCO1, PRMT1, PPARBP </it>and <it>CREBBP</it>) suggested to influence transcriptional activation by steroid hormone receptors in a multiethnic panel of women with advanced breast cancer (n = 95): African Americans, Latinos, Japanese, Native Hawaiians and European Americans. Association testing of validated coding variants was conducted in a breast cancer case-control study (1,612 invasive cases and 1,961 controls) nested in the Multiethnic Cohort. We used logistic regression to estimate odds ratios for allelic effects in ethnic-pooled analyses as well as in subgroups defined by disease stage and steroid hormone receptor status. We also investigated effect modification by established breast cancer risk factors that are associated with steroid hormone exposure.</p> <p>Results</p> <p>We identified 45 coding variants with frequencies ≥ 1% in any one ethnic group (43 non-synonymous variants). We observed nominally significant positive associations with two coding variants in ethnic-pooled analyses (<it>NCOR2</it>: His52Arg, OR = 1.79; 95% CI, 1.05–3.05; <it>CALCOCO1</it>: Arg12His, OR = 2.29; 95% CI, 1.00–5.26). A small number of variants were associated with risk in disease subgroup analyses and we observed no strong evidence of effect modification by breast cancer risk factors. Based on the large number of statistical tests conducted in this study, the nominally significant associations that we observed may be due to chance, and will need to be confirmed in other studies.</p> <p>Conclusion</p> <p>Our findings suggest that common coding variation in these candidate genes do not make a substantial contribution to breast cancer risk in the general population. Cataloging and testing of coding variants in coactivator and corepressor genes should continue and may serve as a valuable resource for investigations of other hormone-related phenotypes, such as inter-individual response to hormonal therapies used for cancer treatment and prevention.</p
The XMM Cluster Survey: Forecasting cosmological and cluster scaling-relation parameter constraints
We forecast the constraints on the values of sigma_8, Omega_m, and cluster
scaling relation parameters which we expect to obtain from the XMM Cluster
Survey (XCS). We assume a flat Lambda-CDM Universe and perform a Monte Carlo
Markov Chain analysis of the evolution of the number density of galaxy clusters
that takes into account a detailed simulated selection function. Comparing our
current observed number of clusters shows good agreement with predictions. We
determine the expected degradation of the constraints as a result of
self-calibrating the luminosity-temperature relation (with scatter), including
temperature measurement errors, and relying on photometric methods for the
estimation of galaxy cluster redshifts. We examine the effects of systematic
errors in scaling relation and measurement error assumptions. Using only (T,z)
self-calibration, we expect to measure Omega_m to +-0.03 (and Omega_Lambda to
the same accuracy assuming flatness), and sigma_8 to +-0.05, also constraining
the normalization and slope of the luminosity-temperature relation to +-6 and
+-13 per cent (at 1sigma) respectively in the process. Self-calibration fails
to jointly constrain the scatter and redshift evolution of the
luminosity-temperature relation significantly. Additional archival and/or
follow-up data will improve on this. We do not expect measurement errors or
imperfect knowledge of their distribution to degrade constraints significantly.
Scaling-relation systematics can easily lead to cosmological constraints 2sigma
or more away from the fiducial model. Our treatment is the first exact
treatment to this level of detail, and introduces a new `smoothed ML' estimate
of expected constraints.Comment: 28 pages, 17 figures. Revised version, as accepted for publication in
MNRAS. High-resolution figures available at http://xcs-home.org (under
"Publications"
Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent
Prostate cancer (CaP) is the leading cancer among men of African descent in the USA, Caribbean, and Sub-Saharan Africa (SSA). The estimated number of CaP deaths in SSA during 2008 was more than five times that among African Americans and is expected to double in Africa by 2030. We summarize publicly available CaP data and collected data from the men of African descent and Carcinoma of the Prostate (MADCaP) Consortium and the African Caribbean Cancer Consortium (AC3) to evaluate CaP incidence and mortality in men of African descent worldwide. CaP incidence and mortality are highest in men of African descent in the USA and the Caribbean. Tumor stage and grade were highest in SSA. We report a higher proportion of T1 stage prostate tumors in countries with greater percent gross domestic product spent on health care and physicians per 100,000 persons. We also observed that regions with a higher proportion of advanced tumors reported lower mortality rates. This finding suggests that CaP is underdiagnosed and/or underreported in SSA men. Nonetheless, CaP incidence and mortality represent a significant public health problem in men of African descent around the world
Genetic Analysis of Human Traits In Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines
Lymphoblastoid cell lines (LCLs), originally collected as renewable sources of DNA, are now being used as a model system to study genotype–phenotype relationships in human cells, including searches for QTLs influencing levels of individual mRNAs and responses to drugs and radiation. In the course of attempting to map genes for drug response using 269 LCLs from the International HapMap Project, we evaluated the extent to which biological noise and non-genetic confounders contribute to trait variability in LCLs. While drug responses could be technically well measured on a given day, we observed significant day-to-day variability and substantial correlation to non-genetic confounders, such as baseline growth rates and metabolic state in culture. After correcting for these confounders, we were unable to detect any QTLs with genome-wide significance for drug response. A much higher proportion of variance in mRNA levels may be attributed to non-genetic factors (intra-individual variance—i.e., biological noise, levels of the EBV virus used to transform the cells, ATP levels) than to detectable eQTLs. Finally, in an attempt to improve power, we focused analysis on those genes that had both detectable eQTLs and correlation to drug response; we were unable to detect evidence that eQTL SNPs are convincingly associated with drug response in the model. While LCLs are a promising model for pharmacogenetic experiments, biological noise and in vitro artifacts may reduce power and have the potential to create spurious association due to confounding
Recommended from our members
Detectable Clonal Mosaicism from Birth to Old Age and its Relationship to Cancer
Clonal mosaicism for large chromosomal anomalies (duplications, deletions and uniparental disomy) was detected using SNP microarray data from over 50,000 subjects recruited for genome-wide association studies. This detection method requires a relatively high frequency of cells (>5–10%) with the same abnormal karyotype (presumably of clonal origin) in the presence of normal cells. The frequency of detectable clonal mosaicism in peripheral blood is low (<0.5%) from birth until 50 years of age, after which it rises rapidly to 2–3% in the elderly. Many of the mosaic anomalies are characteristic of those found in hematological cancers and identify common deleted regions that pinpoint the locations of genes previously associated with hematological cancers. Although only 3% of subjects with detectable clonal mosaicism had any record of hematological cancer prior to DNA sampling, those without a prior diagnosis have an estimated 10-fold higher risk of a subsequent hematological cancer (95% confidence interval = 6–18)
BioSimulators: a central registry of simulation engines and services for recommending specific tools
Computational models have great potential to accelerate bioscience, bioengineering, and medicine. However, it remains challenging to reproduce and reuse simulations, in part, because the numerous formats and methods for simulating various subsystems and scales remain siloed by different software tools. For example, each tool must be executed through a distinct interface. To help investigators find and use simulation tools, we developed BioSimulators (https://biosimulators.org), a central registry of the capabilities of simulation tools and consistent Python, command-line and containerized interfaces to each version of each tool. The foundation of BioSimulators is standards, such as CellML, SBML, SED-ML and the COMBINE archive format, and validation tools for simulation projects and simulation tools that ensure these standards are used consistently. To help modelers find tools for particular projects, we have also used the registry to develop recommendation services. We anticipate that BioSimulators will help modelers exchange, reproduce, and combine simulations
- …